Toggle navigation
Login
Toggle navigation
JavaScript is disabled for your browser. Some features of this site may not work without it.
eEF2K Activity Determines Synergy to Cotreatment of Cancer Cells With PI3K and MEK Inhibitors
QMRO Home
Barts Cancer Institute
Centre for Haemato-Oncology
eEF2K Activity Determines Synergy to Cotreatment of Cancer Cells With PI3K and MEK Inhibitors
QMRO Home
Barts Cancer Institute
Centre for Haemato-Oncology
eEF2K Activity Determines Synergy to Cotreatment of Cancer Cells With PI3K and MEK Inhibitors
Browse
All of QMRO
Communities & Collections
By Issue Date
Authors
Titles
Subjects
This Collection
By Issue Date
Authors
Titles
Subjects
Administrators only
Login
Statistics
Most Popular Items
Statistics by Country
Most Popular Authors
eEF2K Activity Determines Synergy to Cotreatment of Cancer Cells With PI3K and MEK Inhibitors
View/
Open
Accepted version (3.391Mb)
Volume
21
DOI
10.1016/j.mcpro.2022.100240
Journal
MOLECULAR & CELLULAR PROTEOMICS
Issue
6
Metadata
Show full item record
Authors
Hijazi, M; Casado, P; Akhtar, N; Alvarez-Teijeiro, S; Rajeeve, V; Cutillas, PR
URI
https://qmro.qmul.ac.uk/xmlui/handle/123456789/80591
Collections
Centre for Haemato-Oncology
[214]
Licence information
This is an open access article under the CC BY license (http://creativecommons.org/ licenses/by/4.0/).
Copyright statements
© 2022 THE AUTHORS. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.